Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | 3702 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | 3832 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | 4534 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | 4629 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | 4878 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | 4969 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | 5587 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | Severe disease | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | 3417 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | 3702 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | 3732 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | 4607 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | 4629 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | 4819 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | 5013 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | Healthy control | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | Mild disease | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 2754 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | 2816 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+ | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | 1652 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M+H)+[-H2O] | Peak area | Severe disease | |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 2754 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | 2816 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | Peak area | Healthy control | |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | Peak area | Mild disease | |
Reversed phase POSITIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M+H)+ | Peak area | Severe disease |